This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Braunlin, W. Articles by Kurtz, C. B. Search for Related Content PubMed PubMed Citation Articles by Braunlin, W. Articles by Kurtz, C. B.

Toxin Binding of Tolevamer, a Polyanionic Drug that Protects against Antibiotic-Associated Diarrhea

Genzyme Corporation, Waltham, Massachusetts 02451

Correspondence: Address reprint requests to Caroline Kurtz, Microbia, Inc., 320 Bent St., Cambridge, MA 02141. Tel.: 617-621-7722.

Tolevamer, (GT160-246), is a sodium salt of styrene sulfonate polymer that is under development for the treatment of diarrhea caused by infection with Clostridium difficile. Pulsed ultrafiltration binding experiments in phosphate buffer containing 0.15 M Na⁺ provide per polymer chain dissociation constants of 133 nM and 8.7 µM for the binding of tolevamer to C. difficile toxins A and B, respectively. At 0.05 M Na⁺, the binding of toxin A to tolevamer is irreversible, whereas the dissociation constant to toxin B under these conditions is 120 nM. Binding constants obtained from fluorescence polarization data for toxin A binding to tolevamer at 0.15 M Na⁺ agree substantially with those obtained by pulsed ultrafiltration. The binding activity of tolevamer reported here correlates well with previously reported results for the inhibition of the biological activity of C. difficile toxins A and B. From the fluorescence polarization data, it is estimated that one toxin A molecule interacts with between 600 to 1000 monomer units on tolevamer at 0.15 M Na⁺. Thus, the data suggest a very large interaction surface between polymer and toxin A.

This article has been cited by other articles:

				P. L. Hinkson, C. Dinardo, D. DeCiero, J. D. Klinger, and R. H. Barker Jr. Tolevamer, an Anionic Polymer, Neutralizes Toxins Produced by the BI/027 Strains of Clostridium difficile Antimicrob. Agents Chemother., June 1, 2008; 52(6): 2190 - 2195. [Abstract] [Full Text] [PDF]

				T. Z Jodlowski, R. Oehler, L. W Kam, and I. Melnychuk Emerging Therapies in the Treatment of Clostridium difficile-Associated Disease Ann. Pharmacother., December 1, 2006; 40(12): 2164 - 2169. [Abstract] [Full Text] [PDF]

				J. G. S. Ho, A. Greco, M. Rupnik, and K. K.-S. Ng Crystal structure of receptor-binding C-terminal repeats from Clostridium difficile toxin A PNAS, December 20, 2005; 102(51): 18373 - 18378. [Abstract] [Full Text] [PDF]